CN Patent

CN119930422A — 贝派度酸及其中间体的制备方法和其中间体

Assigned to Yangzhou Aoruite Pharmaceutical Co ltd · Expires 2025-05-06 · 1y expired

What this patent protects

本发明提供了贝派度酸及其中间体的制备方法和其中间体，所述制备方法以新颖的中间体化合物6为原料，经水解、脱羟基保护基和还原得到贝派度酸，中间体化合物6可利用己内酯为起始物料，己内酯经自身缩合后，开环、溴化、羰基保护和α烷基化得到化合物6。本发明的贝派度酸的制备方法操作简便安全、收率高，生产成本低、易于工业生产。

USPTO Abstract

本发明提供了贝派度酸及其中间体的制备方法和其中间体，所述制备方法以新颖的中间体化合物6为原料，经水解、脱羟基保护基和还原得到贝派度酸，中间体化合物6可利用己内酯为起始物料，己内酯经自身缩合后，开环、溴化、羰基保护和α烷基化得到化合物6。本发明的贝派度酸的制备方法操作简便安全、收率高，生产成本低、易于工业生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN119930422A
Jurisdiction
CN
Classification
—
Expires
2025-05-06
Drug substance claim
No
Drug product claim
No
Assignee
Yangzhou Aoruite Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.